DE69828196D1 - Verfahren zur vorbeugung und behandlung bakterieller infektionen unter verwendung von celluloseacetatphthalat- oder hydroxyproppylmethylcelluloseträgerstoffen - Google Patents

Verfahren zur vorbeugung und behandlung bakterieller infektionen unter verwendung von celluloseacetatphthalat- oder hydroxyproppylmethylcelluloseträgerstoffen

Info

Publication number
DE69828196D1
DE69828196D1 DE69828196T DE69828196T DE69828196D1 DE 69828196 D1 DE69828196 D1 DE 69828196D1 DE 69828196 T DE69828196 T DE 69828196T DE 69828196 T DE69828196 T DE 69828196T DE 69828196 D1 DE69828196 D1 DE 69828196D1
Authority
DE
Germany
Prior art keywords
preventing
acetate phthalate
hpmcp
cap
cellulose acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69828196T
Other languages
English (en)
Other versions
DE69828196T2 (de
Inventor
Robert Neurath
Shibo Jiang
Kumar Debnath
Nathan Strick
Jay Dow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Blood Center Inc
Original Assignee
New York Blood Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/112,130 external-priority patent/US5985313A/en
Application filed by New York Blood Center Inc filed Critical New York Blood Center Inc
Publication of DE69828196D1 publication Critical patent/DE69828196D1/de
Application granted granted Critical
Publication of DE69828196T2 publication Critical patent/DE69828196T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
DE69828196T 1997-10-22 1998-10-21 Verfahren zur vorbeugung und behandlung bakterieller infektionen unter verwendung von celluloseacetatphthalat- oder hydroxyproppylmethylcelluloseträgerstoffen Expired - Fee Related DE69828196T2 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US6293697P 1997-10-22 1997-10-22
US62936P 1997-10-22
US7101798P 1998-01-13 1998-01-13
US71017P 1998-01-13
US112130 1998-07-08
US09/112,130 US5985313A (en) 1997-10-22 1998-07-08 Method for decreasing the frequency of transmission of viral infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients
US09/175,909 US6165493A (en) 1997-10-22 1998-10-20 "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
US175909 1998-10-20
PCT/US1998/022184 WO1999020098A1 (en) 1997-10-22 1998-10-21 Methods for preventing and treating bacterial infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients

Publications (2)

Publication Number Publication Date
DE69828196D1 true DE69828196D1 (de) 2005-01-20
DE69828196T2 DE69828196T2 (de) 2006-02-23

Family

ID=27490333

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69828196T Expired - Fee Related DE69828196T2 (de) 1997-10-22 1998-10-21 Verfahren zur vorbeugung und behandlung bakterieller infektionen unter verwendung von celluloseacetatphthalat- oder hydroxyproppylmethylcelluloseträgerstoffen

Country Status (9)

Country Link
US (1) US6165493A (de)
EP (1) EP1030547B1 (de)
JP (1) JP2001520171A (de)
AT (1) ATE284675T1 (de)
AU (1) AU1271799A (de)
BR (1) BR9813137A (de)
CA (1) CA2305331C (de)
DE (1) DE69828196T2 (de)
WO (1) WO1999020098A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
US6462030B1 (en) * 1999-07-19 2002-10-08 New York Blood Center, Inc. Method for inactivating bacteria associated with bacterial vaginosis using cellulose acetate phthalate and/or hydroxypropyl methycellulose phthalate
US6541517B1 (en) * 1999-09-03 2003-04-01 Donald M. Murphy Treatment of skin disorders
ES2170622B1 (es) * 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
US6835717B2 (en) * 2000-03-08 2004-12-28 The Johns Hopkins University School Of Medicine β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
US6541542B2 (en) 2000-09-29 2003-04-01 Eastman Chemical Company Process for production of polymeric powders
US6572875B2 (en) 2000-10-30 2003-06-03 New York Blood Center, Inc. Biodegradable microbicidal vaginal barrier device
US6596297B2 (en) 2000-10-30 2003-07-22 New York Blood Center, Inc. Biodegradable microbicidal vaginal barrier device
JP2002154906A (ja) 2000-11-13 2002-05-28 Michio Hayashi 抗菌剤組成物
US20030133829A1 (en) * 2001-12-21 2003-07-17 Baxter Healthcare Corporation Process for inactivating pathogens in a biological material
AR039540A1 (es) * 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
GB2398496A (en) * 2003-02-20 2004-08-25 Reckitt Benckiser Healthcare Suspensions of water-swellable polymer particles which are substantially water-free or contain insufficient water to fully swell the particles
US20050070501A1 (en) * 2003-09-29 2005-03-31 New York Blood Center, Inc. Water dispersible film
CN102276732B (zh) 2003-11-28 2016-01-20 伊士曼化工公司 纤维素共聚体和氧化方法
US20060021302A1 (en) * 2004-07-30 2006-02-02 Bernard Bobby L Anti-microbial air filter
US20070082035A1 (en) * 2005-10-06 2007-04-12 New York Blood Center, Inc. Anti-infective hygiene products based on cellulose acetate phthalate
US7772213B2 (en) * 2006-07-27 2010-08-10 Nathan Strick Composition for the treatment of inflammatory conditions
JP2010516772A (ja) * 2007-01-26 2010-05-20 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド 免疫機能を調節する方法
CA2687310A1 (en) * 2007-05-24 2008-12-04 New York Blood Center Inc. Rapidly dispersible vaginal tablet that provides a bioadhesive gel
CA2703585A1 (en) 2007-10-23 2009-04-30 The Regents Of The University Of Colorado Competitive inhibitors of invariant chain expression and/or ectopic clip binding
US20090234027A1 (en) * 2008-03-14 2009-09-17 Nathan Strick Topical gel cosmetic formulation of cellacefate for the control of acne and rosacea
CA2658440C (en) 2008-04-04 2016-08-23 Kraft Foods Global Brands Llc Dairy composition with probiotics and anti-microbial system
US20100166782A1 (en) * 2008-07-25 2010-07-01 Martha Karen Newell Clip inhibitors and methods of modulating immune function
AU2009274568A1 (en) * 2008-07-25 2010-01-28 The Regents Of The University Of Colorado Proteins for use in diagnosing and treating infection and disease
EP2323681A4 (de) * 2008-07-25 2012-11-14 Univ Colorado Verfahren zur behandlung viraler erkrankungen
US20110189221A1 (en) * 2008-10-31 2011-08-04 Van Olphen Alberto Novel antiviral compounds from marine extracts
JP5903718B2 (ja) 2010-08-09 2016-04-13 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル Ｈｉｖ−１感染の処置のための方法及び医薬的組成物
KR20160046879A (ko) 2013-09-25 2016-04-29 조에티스 서비시즈 엘엘씨 Pcv2b 분지형 백신 조성물 및 사용 방법
CA3026108A1 (en) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Non-comedogenic hair and scalp care formulations and method for use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4518433A (en) * 1982-11-08 1985-05-21 Fmc Corporation Enteric coating for pharmaceutical dosage forms
US4462839A (en) * 1983-06-16 1984-07-31 Fmc Corporation Enteric coating for pharmaceutical dosage forms
EP0309527B1 (de) * 1987-04-16 1993-01-20 Christian Bindschaedler Verfahren zur herstellung eines wasserunlöslichen polymerpulvers, das in einer flüssigen phase redispergiert werden kann und verfahren zur herstellung einer dispersion des polymerpulvers
US5025004A (en) * 1988-06-13 1991-06-18 Eastman Kodak Company Water-dispersible polymeric compositions
US4960814A (en) * 1988-06-13 1990-10-02 Eastman Kodak Company Water-dispersible polymeric compositions
US5326572A (en) * 1989-03-23 1994-07-05 Fmc Corporation Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions
US5356634A (en) * 1992-11-13 1994-10-18 Eastman Chemical Company Controlled-release delivery system
US5380790A (en) * 1993-09-09 1995-01-10 Eastman Chemical Company Process for the preparation of acrylic polymers for pharmaceutical coatings
JP3492787B2 (ja) * 1994-04-15 2004-02-03 信越化学工業株式会社 固形製剤のコーティング用水性エマルジョンの濃縮方法
EP0706794B1 (de) * 1994-10-14 2001-12-12 Japan Energy Corporation AIDS-hemmende Arzneizubereitung und Verfahren
US5723151A (en) * 1995-11-06 1998-03-03 Eastman Chemical Company Cellulose acetate phthalate enteric coating compositions
US5646151A (en) * 1996-03-08 1997-07-08 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof

Also Published As

Publication number Publication date
WO1999020098A1 (en) 1999-04-29
CA2305331C (en) 2008-04-29
EP1030547A1 (de) 2000-08-30
EP1030547B1 (de) 2004-12-15
AU1271799A (en) 1999-05-10
BR9813137A (pt) 2000-08-15
DE69828196T2 (de) 2006-02-23
CA2305331A1 (en) 1999-04-29
ATE284675T1 (de) 2005-01-15
EP1030547A4 (de) 2002-11-06
US6165493A (en) 2000-12-26
JP2001520171A (ja) 2001-10-30

Similar Documents

Publication Publication Date Title
DE69828196D1 (de) Verfahren zur vorbeugung und behandlung bakterieller infektionen unter verwendung von celluloseacetatphthalat- oder hydroxyproppylmethylcelluloseträgerstoffen
CA2258217A1 (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
HUP0100100A2 (hu) Hepatitis C inhibitor peptid-analógok, ezeket hatóanyagként tartalmazó gyógyszerkészítmények és alkalmazásuk
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
FI951468A0 (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
DE3486160T2 (de) Modifizierte lebende Pseudo-Rabies-Viren, diese enthaltende Impfstoffe gegen Pseudo-Rabies, Verfahren zur Herstellung und Verfahren zur Verwendung derselben.
ID27787A (id) Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
AU3855297A (en) Pharmaceutical composition for treating papillomavirus tumours and infection
DE69023648T2 (de) Herstellung eines virus und reinigung von virenüberzugsproteinen zur impfstoffverwendung.
WO1997005899A3 (en) Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
UA35639C2 (uk) Спосіб одержання композиції очищеного капсидного білка вірусу папіломи людини
DE68923169T2 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
ATE380034T1 (de) Neues verfahren zur herstellung von virus- ähnlichen partikeln des menschen-papillomavirus mit verbesserten eigenschaften
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
WO1999053950A3 (en) Live vaccines and methods of treatment therewith
WO2000040242A3 (de) Herstellung eines mittels gegen hepatitis b-, hi-, paramyxo- und orthomyxo-viren
UA74388C2 (uk) Фармацевтичні композиції тизоксаніду і нітазоксаніду
MX9602256A (es) Vacuna contra la enfermedad de marek.
DE69933891D1 (de) Behandlung von papillomavirus-infektionen
DE60017194D1 (de) Verfahren zur herstellung von carbapenem-antibiotika zubereitungen
FI972389A (fi) Uusi menetelmä ranitidiinin valmistamiseksi
MX9702769A (es) Mejoras en una linea de celulas sustentable o estable para la produccion de vacunas para la enfermedad de marek.
KR970701561A (ko) 신규 기도부 바이러스 질환 치료제(Novel Remedy for Respiratory-Tract Viral Disease)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NEW YORK BLOOD CENTER, INC., NEW YORK, N.Y., US

8328 Change in the person/name/address of the agent

Representative=s name: PATENTANWAELTE ZELLENTIN & PARTNER GBR, 80331 MUENCHEN

8339 Ceased/non-payment of the annual fee